Surgical Science Sweden AB (publ)
SUSRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,657,914 | $7,269,978 | $6,277,837 | $8,201,936 |
| - Cash | $597,387 | $610,219 | $612,891 | $968,155 |
| + Debt | $1,625 | $1,644 | $1,644 | $235,408 |
| Enterprise Value | $4,062,152 | $6,661,403 | $5,666,590 | $7,469,189 |
| Revenue | $263,641 | $209,157 | $250,691 | $251,549 |
| % Growth | 26% | -16.6% | -0.3% | – |
| Gross Profit | $170,430 | $136,394 | $172,599 | $170,075 |
| % Margin | 64.6% | 65.2% | 68.8% | 67.6% |
| EBITDA | $27,249 | -$22,387 | $23,938 | $39,127 |
| % Margin | 10.3% | -10.7% | 9.5% | 15.6% |
| Net Income | $20,402 | -$20,077 | $33,237 | $36,264 |
| % Margin | 7.7% | -9.6% | 13.3% | 14.4% |
| EPS Diluted | 0.4 | -0.39 | 0.65 | 0.71 |
| % Growth | 202.6% | -160% | -8.5% | – |
| Operating Cash Flow | -$4,368 | $16,223 | -$4,958 | $56,668 |
| Capital Expenditures | -$10,923 | -$12,597 | -$10,695 | -$12,127 |
| Free Cash Flow | -$15,291 | $3,626 | -$15,653 | $44,541 |